Business Context and Reporting Period
This Form 8-K is a current report filed by Landec Corporation (not Lifecore Biomedical, Inc.) on February 5, 2019, regarding events occurring on January 31, 2019. The filing details the execution of new Executive Employment Agreements with the Company's President and CEO, Molly A. Hemmeter, and its CFO, Gregory S. Skinner.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation terms:
- CEO Base Salary: $525,000 annually.
- CFO Base Salary: $380,000 annually.
- Contract Term: Expires December 31, 2021, unless renewed.
- Incentives: Eligible for annual cash bonuses based on goals and equity grants under the 2013 Stock Incentive Plan.
Material Changes
The new agreements terminate and replace the previous Executive Employment Agreements dated October 15, 2015. The primary material changes involve updated compensation structures and specific severance provisions tied to termination without cause, "good reason," or a change of control.
Outlook, Risks, and Contingencies
Severance Provisions:
- Standard Termination (Without Cause/Good Reason): Executives receive 100% of annual base salary, pro-rated bonus, one-year acceleration of equity vesting, and COBRA health coverage.
- Change of Control Termination (Within 2 years): Executives receive 150% of annual base salary, pro-rated bonus, full immediate vesting of all unvested equity, and COBRA health coverage.
Restrictive Covenants: Both executives agreed to a two-year non-solicitation period regarding employees, consultants, licensors, and customers following termination.
Investor Verification Checklist
- Verify the exact terms of the "good reason" definition in the full text of Exhibits 10.1 and 10.2.
- Review the Company's 2013 Stock Incentive Plan to understand the current pool availability for future equity grants.
- Assess the potential financial impact of the 150% severance payout in the event of a near-term change of control.
- Confirm the specific performance goals tied to the annual cash incentive awards, which are not detailed in this summary.